Ceryvyn Therapeutics Limited (ASX:CYV)
Australia · Delayed Price · Currency is AUD 0.0110
0.00 (0.00%)
Aug 5, 2026, 4:11 PM AEST
Ceryvyn Therapeutics Market Cap
Ceryvyn Therapeutics has a market cap or net worth of 15.05 million as of August 5, 2026. Its market cap has decreased by -97.96% in one year.
Market Cap
15.05M
Enterprise Value
-18.12M
Revenue
-20.12K
Ranking
n/a
PE Ratio
0.05
Stock Price
0.01
ChartMarket Cap Chart
Since May 13, 1996, Ceryvyn Therapeutics's market cap has decreased from 39.30M to 15.05M, a decrease of -61.71%. That is a compound annual growth rate of -3.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 15.05M | -98.49% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Noxopharm | 25.19M |
| Algorae Pharmaceuticals | 24.31M |
| Proteomics International Laboratories | 23.95M |
| NeuroScientific Biopharmaceuticals | 23.38M |
| EZZ Life Science Holdings | 22.59M |
| Patrys | 22.00M |
| Neurotech International | 21.08M |
| Argenica Therapeutics | 19.91M |